Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2

Journal of Alzheimer's Disease

Volumn 25, Issue 3, 2011, Pages 455-462

  Elliott Hunt, Caroline R ^a   Holmes, Fiona E ^a   Hartley, Dean M ^b   Perez, Sylvia ^b   Mufson, Elliott J ^b   Wynick, David ^a,c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

Author keywords

Alzheimer's disease; amyloid toxicity; GAL(2); galanin; neuroprotection; transgenic models

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; GALANIN; GALANIN RECEPTOR 2;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; HIPPOCAMPUS; LOSS OF FUNCTION MUTATION; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 79960807183     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110011     Document Type: Article

References (53)

1. Haass C, Selkoe DJ (1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75, 1039-1042.
2. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cere-brovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890. (Pubitemid 14104991)
3. Lombardo JA, Stern EA, McLellan ME, Kajdasz ST, Hickey GA, Bacskai BJ, Hyman BT (2003) Amyloid-beta antibody treatment leads to rapid normalization ofplaque-induced neu-ritic alterations. J Neurosci 23, 10879-10883. (Pubitemid 37499696)
4. Selkoe DJ (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271, 18295-18298. (Pubitemid 26322675)
5. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791. (Pubitemid 35231524)
6. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL (1995) Neurochemical correlatesofdementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neu-rochem 64, 749-760.
7. Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 164, 124-128. (Pubitemid 14201839)
8. Evans HF, Shine J (1991) Human galanin: molecular cloning reveals a unique structure. Endocrinology 129, 1682-1684.
9. Chan-Palay V (1988) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 273, 543-557.
10. Mufson EJ, Cochran E, Benzing W, Kordower JH (1993) Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria termi-nalis in aging, Alzheimer's disease and Down's syndrome. Dementia 4, 237-250. (Pubitemid 23281684)
11. Bowser R, Kordower JH, Mufson EJ (1997) A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol 72, 723-730. (Pubitemid 27234246)
12. Chan-Palay V (1991) Alterations in the locus coeruleus in dementiasof Alzheimer's and Parkinson'sdisease.Prog Brain Res 88, 625-630.
13. Gabriel SM, Knott PJ, Haroutunian V (1995) Alterations in cerebral cortical galanin concentrations following neurotransmitter-specific subcortical lesions in the rat. J Neu-rosci 15, 5526-5534.
14. Mufson EJ, Deecher DC, Basile M, Izenwasse S, Mash DC (2000) Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradio-graphic analysis. Neuropharmacology 39, 1404-1412. (Pubitemid 30249202)
15. Rodriguez-Puertas R, Nilsson S, Pascual J, Pazos A, Hokfelt T (1997) 125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus. J Neurochem 68, 1106-1113. (Pubitemid 27086215)
16. Perez S, Basile M, Mash DC, Mufson EJ (2002) Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis. J Chem Neuroanat 24, 109-116. (Pubitemid 35007327)
17. McMillan PJ, Peskind E, Raskind MA, Leverenz JB (2004) Increased galanin receptor occupancy in Alzheimer's disease. Neurobiol Aging 25, 1309-1314. (Pubitemid 39299168)
18. Mufson EJ, Counts SE, Perez SE, Binder L (2005) Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Neuropeptides 39, 233-237. (Pubitemid 40804590)
19. Diez M, Danner S, Frey P, Sommer B, Staufenbiel M, Wieder-hold KH, Hokfelt T (2003) Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice over-expressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23). Neurobiol Dis 14, 579-594. (Pubitemid 37543535)
20. Wrenn CC, Crawley JN (2001) Pharmacological evidence supporting a role for galanin in cognition and affect. Prog Neuro-Psychoph 25, 283-299. (Pubitemid 32173796)
21. Sundstrom E, Archer T, Melander T, Hokfelt T (1988) Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neurosci Lett 88, 331-335.
22. Schott PA, Hokfelt T, Ogren SO (2000) Galanin and spatial learning in the rat. Evidence for a differential role for galanin in subregions of the hippocampal formation. Neuropharm 39, 1386-1403. (Pubitemid 30249201)
23. Ogren SO, Schott PA, Kehr J, Misane I, Razani H (1999) Galanin and learning. Brain Res 848, 174-182. (Pubitemid 30001666)
24. Valkna A, Jureus A, Karelson E, Zilmer M, Bartfai T, Langel U (1995) Differential regulation of adenylate cyclase activity in rat ventral and dorsal hippocampus by rat galanin. Neurosci Lett 187, 75-78.
25. Steiner RA, Hohmann JG, Holmes A, Wrenn CC, Cadd G, Jureus A, Clifton DK, Luo M, Gutshall M, Ma SY, Mufson EJ, Crawley JN (2001) Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc Natl Acad Sci U S A 98, 4184-4189. (Pubitemid 32249919)
26. Kuteeva E, Hokfelt T, Ove OS (2005) Behavioural characterisation of transgenic mice overexpressing galanin under the PDGF-B promoter. Neuropeptides 39, 297-302.
27. Holmes FE, Bacon A, Pope RJ, Vanderplank PA, Kerr NC, Sukumaran M, Pachnis V, Wynick D (2003) Transgenic over-expression of galanin in the dorsal root ganglia modulates pain-related behavior. Proc Natl Acad Sci U S A 100, 6180-6185. (Pubitemid 36576951)
28. Wynick D, Small CJ, Bacon A, Holmes FE, Norman M, Ormandy CJ, Kilic E, Kerr NCH, Ghatei M, Talamantes F, Bloom SR, Pachnis V (1998) Galanin regulates prolactin release and lactotroph proliferation. Proc Natl Acad Sci U S A 95, 12671-12676. (Pubitemid 28483823)
29. Holmes FE, Mahoney S, King VR, Bacon A, Kerr NCH, Pachnis V, Curtis R, Priestley JV, Wynick D (2000) Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc Natl Acad Sci U S A 97, 11563-11568.
30. O'Meara G, Coumis U, Ma SY, Kehr J, Mahoney S, Bacon A, Allen SJ, Holmes F, Kahl U, Wang FH, Kearns IR, Ove-Ogren S, Dawbarn D, Mufson EJ, Davies C, Dawson G, Wynick D (2000) Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A 97, 11569-11574.
31. Mahoney SA, Hosking R, Farrant S, Holmes FE, Jacoby AS, Shine J, Iismaa TP, Scott MK, Schmidt R, Wynick D (2003) The second galanin receptor Gal R2 plays a key role in neurite outgrowth from adult sensory neurons. J Neurosci 23, 416-421. (Pubitemid 36139540)
32. Hobson SA, Holmes FE, Kerr NCH, Pope RJ, Wynick D (2006) Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour. J Neurochem 99, 1000-1010. (Pubitemid 44583456)
33. Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, Hokfelt T (2001) Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via Gal R1 and Gal R2 receptors. Proc Natl Acad Sci U S A 98, 9960-9964. (Pubitemid 32769410)
34. Lu X, Lundstrom L, Bartfai T (2005) Galanin (2-11) binds to Gal R3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides 39, 165-167. (Pubitemid 40804579)
35. Elliott-Hunt CR, Marsh B, Bacon A, Pope R, Vanderplank P, Wynick D (2004) Galanin acts as a neuroprotective factor to the hippocampus. Proc Natl Acad Sci U S A 101, 5105-5110. (Pubitemid 38469210)
36. Elliott-Hunt CR, Pope RJ, Vanderplank P, Wynick D (2007) Activation of the galanin receptor 2 (Gal R2) protects the hippocampus from neuronal damage.J Neurochem100, 780-789. (Pubitemid 46095627)
37. Cheng Y, Yu LC (2010) Galanin protects amyloid-beta-induced neurotoxicity on primary cultured hippocampal neurons of rats. J Alzheimers Dis 20, 1143-1157.
38. Ding X, Mac Tavish D, Kar S, Jhamandas JH (2006) Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol Dis 21, 413-420. (Pubitemid 43099864)
39. Cui J, Chen Q, Yue X, Jiang X, Gao GF, Yu LC, Zhang Y (2010) Galanin protects against intracellular amyloid toxicity in human primary neurons. J Alzheimers Dis 19, 529-544.
40. Pirondi S, Giuliani A, Del VG, Giardino L, Hokfelt T, Calza L (2010) The galanin receptor 2/3 agonist Gal2-11 protects the SN56 cells against beta-amyloid 25-35 toxicity. J Neurosci Res 88, 1064-1073.
41. Counts SE, He B, Che S, Ginsberg SD, Mufson EJ (2009) Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. J Alzheimers Dis 18, 885-896.
42. Bacon A, Holmes FE, Small CJ, Ghatei M, Mahoney S, Bloom SR, Wynick D (2002) Transgenic over-expression of galanin in injured primary sensory neurons. Neuroreport 13, 2129-2132. (Pubitemid 36005939)
43. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Pig-gott J, Beltrandel Rio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van SI, Vogel P, Walke W, Xu N, Zhu Q, Person C, Sands AT (2003) Wnk1 kinase deficiency lowers blood pressureinmice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci U S A 100, 14109-14114. (Pubitemid 37499199)
44. Armstrong SP, Caunt CJ, Finch AR, Mcardle CA (2011) Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function. Mol Cell Endocrinol 331, 194-204.
45. Caunt CJ, Armstrong SP, Mcardle CA (2010) Using high-content microscopy to study gonadotrophin-releasing hormone regulation of ERK. Methods Mol Biol 661, 507-524.
46. Pirondi S, Fernandez M, Schmidt R, Hokfelt T, Giardino L, Calza L (2005) The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells. J Neurochem 95, 821-833. (Pubitemid 41567173)
47. Wang S, Hashemi T, Fried S, Clemmons AL, Hawes BE (1998) Differential intracellular signaling of the Gal R1 and Gal R2 galanin receptor subtypes. Biochemistry (Mosc) 37, 6711-6717. (Pubitemid 28228104)
48. Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G, Gud-ermann T (2000) The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G (q), G (i) and G (12) proteins. Oncogene 19, 4199-4209.
49. Maher P (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J Neu-rosci 21, 2929-2938. (Pubitemid 32323473)
50. Ozawa H, Shioda S, Dohi K, Matsumoto H, Mizushima H, Zhou CJ, Funahashi H, Nakai Y, Nakajo S, Matsumoto K (1999) Delayed neuronal cell death in the rat hippocampus is mediated by the mitogen-activated protein kinase signal transduction pathway. Neurosci Lett 262, 57-60. (Pubitemid 29104958)
51. Culmsee C, Gerling N, Lehmann M, Nikolova-Karakashian M, Prehn JH, Mattson MP, Krieglstein J (2002) Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through Trk A and requires the common neu-rotrophin receptor P75. Neuroscience 115, 1089-1108. (Pubitemid 35351700)
52. Gary DS, Milhavet O, Camandola S, Mattson MP (2003) Essential role for integrin linked kinase in Akt-mediated inte-grin survival signaling in hippocampal neurons. J Neurochem 84, 878-890. (Pubitemid 36176944)
53. Lu X, Roberts E, Xia F, Sanchez-Alavez M, Liu T, Baldwin R, Wu S, Chang J, Wasterlain CG, Bartfai T (2010) Gal R2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc Natl Acad Sci U S A 107, 15229-15234.